Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA committee against approval of vaginal gel to reduce preterm birth

Jan. 23, 2012

Intravenous Bonalon approved in Japan

Jan. 23, 2012

Novel glucagon analogues described

Jan. 23, 2012

Novartis announces CHMP opinion on Signifor

Jan. 23, 2012

Novel chemokine CCR2 receptor antagonists disclosed by Janssen

Jan. 20, 2012

Trimel Pharmaceuticals advances phase III CompleoTRT study

Jan. 20, 2012

FDA issues complete response letter regarding dapagliflozin

Jan. 19, 2012

PROLOR Biotech presents topline data on hGH-CTP

Jan. 19, 2012

Novel compounds acting on urate transporter patented by Ardea Bisociences

Jan. 19, 2012

Ardea Biosciences discloses new inhibitors of urate transport

Jan. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...